skip to main content

Specialized Programs of Research Excellence (SPORE)

Through the Translational Research Program, the National Cancer Institute brings together the experience and expertise of research scientists from across the nation to collaborate in interdisciplinary translational research. This collaborative research effort, called Specialized Program of Research Excellence (SPORE), is a type of research grant awarded by the National Cancer Institute, concentrating on specific cancer types.

Focusing research on prevention, early detection, diagnosis and treatment of the individual cancers, together the SPORE teams are making significant progress to reduce the incidence and mortality by cancer type as well as improve survival and quality of life for cancer patients.

Common Pathway of Cancers

Within each SPORE grant, research scientists and work together to determine a common pathway that ties together the various cancers within a specific organ site or group of highly related cancers. Identifying these themes of cancer types can then expedite the translation or movement of basic scientific findings into the clinical settings to help patients most efficiently. In addition, through observational research, the SPORE teams work to determine the individual or population based biological factors that affect the incidence and progression of these cancers.

University of Michigan Awarded Prostate SPORE Grant

    As one of the first NCI-funded Specialized Programs of Research Excellence (SPORE) in the country, the University of Michigan Prostate SPORE has been in place since 1995. Our team of clinician scientists and researchers strive toward unified goals, including:

    • Foster research productivity
    • Promote interaction and collaboration among researchers
    • Optimize the institution's strengths and unique scientific opportunities to advance prostate cancer prevention, diagnosis, treatment and survivorship

    National Leadership in Translational Research

    Major discoveries made by our clinician scientists and researchers, through strong collaborative efforts, have made our program a national leader in translational research as we strive to reduce the morbidity and mortality associated with prostate cancer. This close collaboration not only includes investigators from across the University of Michigan campus and other SPORE programs at the University of Michigan, but also other institutions, industries, national networks and other Universities have contributed to advance science through translational discovery.

    Learn More about the University of Michigan Prostate SPORE

    For more information about the Prostate Specialized Programs of Research Excellence at the University of Michigan Rogel Cancer Center, contact us or learn more at our Prostate SPORE website.

University of Michigan Awarded Sarcoma SPORE Grant

    The SARC SPORE, one of only two in the country dedicated to sarcoma, is a large-scale collaboration designed to improve the understanding of the underlying biology of sarcoma and to develop novel diagnostic tests and therapies for patients with sarcoma. This collaboration brings together a broad-based multi-disciplinary investigative team anchored by multiple researchers from U-M, the Harvard Cancer Center, the NCI and the University of Texas M.D. Anderson Cancer Center, as well as key leadership from the Albert Einstein College of Medicine, Cancer Research and Biostatistics (CRAB), and Columbia University.